PRJNA731467
Gut microbiota profiling in diverticular diseases before and after rifaximin administration
Investigation of intestinal microbiota's role in symptomatic uncomplicated diverticular disease (SUDD) and of the effect of Rifaximin therapy on gut microbiota variations in patients with SUDD